Penn Presbyerian Medical Center — Philadelphia, Pennsylvania

Penn Presbyerian Medical Center is a clinical research site located in Philadelphia, Pennsylvania, United States 19104.

Crixeo Health Trust Score: 44/100 (POOR). This profile has not yet been claimed by the site owner.

Penn Presbyerian Medical Center has participated in 1 clinical trials.

Therapeutic areas: Transthyretin-mediated Amyloidosis With Cardiomyopathy, ATTR Amyloidosis With Cardiomyopathy.

Sponsors: Alnylam Pharmaceuticals.

Sponsor Feasibility Report

Trust Score: 44/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for Penn Presbyerian Medical Center?

Penn Presbyerian Medical Center has a Crixeo Trust Score of 44/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has Penn Presbyerian Medical Center conducted?

Penn Presbyerian Medical Center has 1 clinical trials on record. Their work covers Transthyretin-mediated Amyloidosis With Cardiomyopathy, ATTR Amyloidosis With Cardiomyopathy.

Is Penn Presbyerian Medical Center accredited by Crixeo Health?

Penn Presbyerian Medical Center has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about Penn Presbyerian Medical Center?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.